Minerva Neurosciences, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 32.11 million compared to USD 49.91 million a year ago. Basic loss per share from continuing operations was USD 6.01 compared to USD 9.35 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.569 USD | -0.24% | +2.34% | -58.23% |
May. 01 | Minerva Neurosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 27 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.23% | 18.01M | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- NERV Stock
- News Minerva Neurosciences, Inc.
- Minerva Neurosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022